Approving cancer treatments based on endpoints other than overall survival: an analysis of historical data using the PACE Continuous Innovation Indicators™ (CII).

Drugs Context · 2017 · PMC5699106 · PMID 29167693

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

marginally significantp = 0.051so close (0.05 < p ≤ 0.1)

A linear regression of E-score per year compared with approval distance yielded a marginally significant result ( p = 0.051) with an R 2 value of 0.091.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.